In July, the HSI and MSCI China index extended their growths, rising 2.9% mom and 4.5% mom respectively to reach their peak on 24 July before pulling pack in the latest week, as investors tend to take profit after the Politburo announcement. With another 90-day tariff delay from the US, we maintain a positive outlook for leading domestic stocks in healthcare and IT. New additions to our BUY list are JBM Healthcare and Lenovo. We take profit on CATL, Han’s Laser, KE Holdings and Longfor.
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in July 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on deve...
WAIC 2025 was held in Shanghai on 26-28 July under the theme "Intelligent Horizons, Shared Future". The focus of WAIC this year shifted from LLM to the next frontier – AI applications and AI agents. As AI capabilities extend from the cloud to edge devices, a transformative evolution in human-AI interaction is underway, characterised by more tangible, embodied forms and empathetic voice interfaces. Maintain MARKET WEIGHT.
June’s HSI and MSCI China Index rose 3.4% mom and 4.0% mom respectively, despite the pullback due to the Middle East tensions. July may see increased volatility as the US looks to bring the tariff negotiations to a close. At this juncture, we continue to favour domestic policy beneficiaries and sector leaders. New additions to our BUY list are CATL, KE Holdings, Longfor, Midea Group, Tencent and Tencent Music Entertainment. We take profit on Prudential.
In today's Morning Views publication we comment on developments of the following high yield issuers: Victoria, Vallourec, Omnia Technologies, Paprec Group, La Doria, Softbank Group, Maxeda, Mahle, Bombardier, Flora Food Group (formerly Upfield), Nexans, Assemblin, Air Baltic, Virgin Media O2, Nokia
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in June 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on deve...
Trade deal in focus. Notwithstanding the 90-day truce on tariff escalation, it is still a 50/50 if there will be a “Big Beautiful Deal” between the US and China. The US is steadfast in wanting to cap China’s growth and restricting her access to the latest technology, while China is making a firm stand on its economic rights. We expect that higher US tariffs on Chinese goods are unavoidable, likely closer to the 60% mark, if Trump were to be seen making a credible move to onshore production in ...
GREATER CHINA Sector Dairy: Retail demand remains weak; expect raw milk supply and demand to reach a temporary balance in 3Q25. Downgrade to MARKET WEIGHT. Hong Kong Landlords: Improved liquidity supporting local spending and lowering finance costs of landlords; upgrade to MARKET WEIGHT; top pick: Wharf REIC. INDONESIA Update Bank Negara Indonesia (BBNI IJ/BUY/Rp4,140/Target: Rp5,200): NIM pressure likely to persist in 2Q25; expect NIM to stabilise in 2H25. MALAYSIA Sector Healthcare: Upgrade ...
THBEV faces stronger competition for its spirits business due to the upcoming regulatory changes but is expected to benefit from lower molasses costs. The domestic beer segment is set to post better margins and has maintained its market share leadership. However, Sabeco continues to face ongoing headwinds from stringent drink-driving laws and higher excise taxes. Management has reiterated that plans for the BeerCo IPO are still ongoing. Maintain HOLD with the same target price of S$0.45.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.